News
PZRXQ
0.0002
NaN%
--
Weekly Report: what happened at PZRXQ last week (0406-0410)?
Weekly Report · 1d ago
Weekly Report: what happened at PZRXQ last week (0330-0403)?
Weekly Report · 04/06 09:31
Weekly Report: what happened at PZRXQ last week (0323-0327)?
Weekly Report · 03/30 09:31
Weekly Report: what happened at PZRXQ last week (0316-0320)?
Weekly Report · 03/23 09:30
Weekly Report: what happened at PZRXQ last week (0309-0313)?
Weekly Report · 03/16 09:29
Weekly Report: what happened at PZRXQ last week (0302-0306)?
Weekly Report · 03/09 09:30
Weekly Report: what happened at PZRXQ last week (0223-0227)?
Weekly Report · 03/02 09:30
Weekly Report: what happened at PZRXQ last week (0216-0220)?
Weekly Report · 02/23 09:30
Weekly Report: what happened at PZRXQ last week (0209-0213)?
Weekly Report · 02/16 09:30
Weekly Report: what happened at PZRXQ last week (0202-0206)?
Weekly Report · 02/09 09:30
Weekly Report: what happened at PZRXQ last week (0126-0130)?
Weekly Report · 02/02 09:30
Weekly Report: what happened at PZRXQ last week (0119-0123)?
Weekly Report · 01/26 09:30
Weekly Report: what happened at PZRXQ last week (0112-0116)?
Weekly Report · 01/19 09:33
Weekly Report: what happened at PZRXQ last week (0105-0109)?
Weekly Report · 01/12 09:32
Weekly Report: what happened at PZRXQ last week (1229-0102)?
Weekly Report · 01/05 09:30
Weekly Report: what happened at PZRXQ last week (1222-1226)?
Weekly Report · 12/29/2025 09:29
Weekly Report: what happened at PZRXQ last week (1215-1219)?
Weekly Report · 12/22/2025 09:29
Weekly Report: what happened at PZRXQ last week (1208-1212)?
Weekly Report · 12/15/2025 09:32
Weekly Report: what happened at PZRXQ last week (1201-1205)?
Weekly Report · 12/08/2025 09:32
Weekly Report: what happened at PZRXQ last week (1124-1128)?
Weekly Report · 12/01/2025 09:30
More
Webull provides a variety of real-time PZRXQ stock news. You can receive the latest news about Phaserx through multiple platforms. This information may help you make smarter investment decisions.
About PZRXQ
Pz Wind Down, Inc., formerly, PhaseRx, Inc. is a biopharmaceutical company developing a portfolio of mRNA products to correct life-threatening inherited liver diseases in children. The Company's initial product development focus is on urea cycle disorders, a group of rare genetic diseases that generally present before the age of 12 and are characterized by the body's inability to remove ammonia from the blood. The Company's i-ERT approach is enabled by its Hybrid mRNA Technology platform and is applicable to a number of inherited liver diseases. The Company is headquartered in Seattle.